Introduction
Chronic Granulomatous Disease (CGD) is a rare primary immunodeficiency characterized by the inability of phagocytes to produce reactive oxygen species, leading to recurrent life-threatening infections and inflammatory complications. Precise genetic diagnosis is vital for clinical management and genetic counseling. This erratum provides a corrected and definitive genetic map for a cohort of 38 pediatric patients in Mainland China, rectifying errors in mutation data for over half of the original study's participants.
Methodology
The underlying study utilized standard molecular biology techniques to characterize the genetic basis of CGD in the cohort. Genomic DNA was extracted from patient blood samples, followed by targeted sequencing of known CGD-associated genes, including CYBB (X-linked), CYBA, NCF1, and NCF2. Bioinformatics tools were employed to map mutations to specific exons or introns and predict their impact on protein structure and function.
Genetic Profile and Key Findings
The corrected dataset reveals a diverse landscape of mutations within the Chinese pediatric population, highlighting both common patterns and unique genetic variants.
Gene Distribution and Mutation Types
The majority of cases (33 out of 38) involved mutations in the CYBB gene, confirming the predominance of X-linked CGD in this cohort. Other cases were attributed to mutations in NCF1 (3 patients) and CYBA (2 patients). The mutations identified include:
- Deletions: Ranging from single nucleotide losses to large contiguous gene deletions (e.g., Patient 23, involving XK, CYBB, and DYNLT3).
- Missense and Nonsense Mutations: Single nucleotide changes resulting in amino acid substitutions or premature stop codons.
- Splicing Errors: Complex mutations at intron-exon junctions leading to exon skipping or aberrant protein assembly.
Novel Variants and Carrier Status
Several novel mutations, previously unreported in global databases at the time of the study, were identified (marked with a ★ in the data table). Screening of family members confirmed maternal carrier status in most X-linked cases, though some instances appeared to be de novo mutations.
Conclusion
This erratum serves as a critical reference for the genetic characterization of CGD in Mainland China. By providing a verified dataset of nucleotide changes and predicted protein alterations, it ensures the accuracy of the molecular features reported for this cohort, facilitating better diagnostic and therapeutic strategies for affected families.
Summary updated